The reduction in price target by Oppenheimer, despite maintaining an Outperform rating, could lead to a negative short-term sentiment among investors. This adjustment reflects a significant change in the expected stock performance, potentially due to revised earnings expectations or market conditions, which might result in a decrease in stock price in the short term.